Key Details
Price
$296.02Last Dividend
$0.89Annual ROE
15.71%Beta
0.43Events Calendar
Next earnings date:
Jan 24, 2025Recent quarterly earnings:
Oct 30, 2024Recent annual earnings:
Jan 25, 2024Next ex-dividend date:
Dec 31, 2024Recent ex-dividend date:
Sept 30, 2024Next split:
N/ARecent split:
Aug 01, 1991Analyst ratings
Recent major analysts updates
Market Data
Dividend
Profitability
Efficiency
Valuation
Liquidity
Cash Flow
Institutional Ownership
Pomerantz LLP is looking into claims for investors of Humana Inc. ("Humana" or the "Company") (NYSE:HUM) as of November 26, 2024. Investors who are interested should reach out to Danielle Peyton at [email protected] or call 646-581-9980, ext.
Pomerantz LLP is looking into claims for investors of Humana Inc. ("Humana" or the "Company") (NYSE:HUM) as of November 20, 2024. Investors who are interested should reach out to Danielle Peyton at [email protected] or call 646-581-9980, ext.
Pomerantz LLP is looking into claims for investors of Humana Inc. ("Humana" or the "Company") (NYSE:HUM) as of November 17, 2024. Investors who are interested should reach out to Danielle Peyton at [email protected] or call 646-581-9980, ext.
Pomerantz LLP is looking into claims for investors of Humana Inc. ("Humana" or the "Company") (NYSE:HUM) as of November 17, 2024. Investors who are interested should reach out to Danielle Peyton at [email protected] or call 646-581-9980, ext.
Pomerantz LLP is looking into claims for investors of Humana Inc. ("Humana" or the "Company") (NYSE:HUM) as of November 16, 2024. Investors who are interested should reach out to Danielle Peyton at [email protected] or call 646-581-9980, ext.
Pomerantz LLP is looking into claims for investors of Humana Inc. ("Humana" or the "Company") (NYSE:HUM) as of November 16, 2024. Investors who are interested should reach out to Danielle Peyton at [email protected] or call 646-581-9980, ext.
Pomerantz LLP is looking into claims for investors of Humana Inc. ("Humana" or the "Company") (NYSE:HUM) as of November 15, 2024. Investors who are interested should reach out to Danielle Peyton at [email protected] or call 646-581-9980, ext.
Pomerantz LLP is looking into claims for investors of Humana Inc. ("Humana" or the "Company") (NYSE:HUM) as of November 15, 2024. Investors who are interested should reach out to Danielle Peyton at [email protected] or call 646-581-9980, ext.
Pomerantz LLP is looking into claims for investors of Humana Inc. ("Humana" or the "Company") (NYSE:HUM) as of November 14, 2024. Investors who are interested should reach out to Danielle Peyton at [email protected] or call 646-581-9980, ext.
Pomerantz LLP is looking into claims for investors of Humana Inc. ("Humana" or the "Company") (NYSE:HUM) as of November 14, 2024. Investors who are interested should reach out to Danielle Peyton at [email protected] or call 646-581-9980, ext.
FAQ
- What is the primary business of Humana?
- What is the ticker symbol for Humana?
- Does Humana pay dividends?
- What sector is Humana in?
- What industry is Humana in?
- What country is Humana based in?
- When did Humana go public?
- Is Humana in the S&P 500?
- Is Humana in the NASDAQ 100?
- Is Humana in the Dow Jones?
- When was Humana's last earnings report?
- When does Humana report earnings?
- Should I buy Humana stock now?